NLS Pharmaceutics Ltd

NASDAQ:NLSP  
3.39
-0.25 (-6.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

NLS Pharmaceutics Ltd Stock, NASDAQ:NLSP

Alter Postplatz 2, Stans, Nidwalden 6370
Switzerland
Phone: +41.41.618.80.00
Number of Employees: 6

Description

NLS Pharmaceutics Ltd. engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder(ADHD). The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.